Physician

Ahmed Sufyan, M.D.

According to 2025 Medicare claims, Ahmed Sufyan, M.D. (NPI: 1710148002) practices otolaryngology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is MID MICHIGAN EAR NOSE AND THROAT PC (NPI: 1326133398; TIN: 383348654) and primary practice location at 48823-1956. Sufyan is affiliated with the POM ACO (ACO ID: A1297), Aledade 57 Western Sky MSSP Enhanced (ACO ID: A4756), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Sufyan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 1,841 HCPCS/CPT codes, and received $129,022 in Medicare payments. The top billing code was 12032 (Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm). Part D data shows 630 prescription claims across 284 beneficiaries totaling $59,815 in drug costs, led by Nucala (Mepolizumab). Open Payments data shows 21 records totaling $630. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $204,256 to $129,022. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,490 and ending at $59,815. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	510	1,207	$204,256
2016	764	1,877	$288,027
2017	723	1,883	$266,415
2018	792	2,080	$296,637
2019	797	2,166	$380,375
2020	538	1,597	$247,412
2021	518	1,766	$230,440
2022	525	2,914	$191,360
2023	478	2,256	$160,163
2024	341	1,841	$129,022

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	249	654	$27,490
2016	306	826	$22,114
2017	280	731	$37,755
2018	342	801	$33,419
2019	264	517	$14,251
2020	347	666	$17,022
2021	394	701	$15,577
2022	372	717	$18,889
2023	346	705	$28,630
2024	284	630	$59,815

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
12032	Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm	43	49	$163
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	80	$81
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	32	32	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	100	$64
95117	Professional service for multiple injections of allergen	43	279	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	14	392	$47,719
Ipratropium Bromide	Ipratropium Bromide	139	4,513	$3,458
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	20	310	$2,468
Fluticasone Propionate	Fluticasone Propionate	124	5,550	$1,956
Cephalexin	Cephalexin	115	737	$1,427

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$630	Integra LifeSciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed Sufyan, M.D.?

Tedicare shows public-source Medicare data for Ahmed Sufyan, M.D. (NPI 1710148002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Sufyan, M.D. have ACO affiliation data?

Ahmed Sufyan, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), Aledade 57 Western Sky MSSP Enhanced (MSSP, ACO ID A4756), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ahmed Sufyan, M.D.?

Ahmed Sufyan, M.D. is linked to MID MICHIGAN EAR NOSE AND THROAT PC (billing NPI 1326133398) in the available physician profile data.

Does Ahmed Sufyan, M.D. have Open Payments data?

Ahmed Sufyan, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.